ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
- Written by PR Newswire Asia - Daily Bulletin Au RSS
Highlights:
- AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR-T cancer immunotherapies against up to five solid tumour antigen targets
- Combining Carina's advanced CAR-T platform technologies with AdAlta's i–body targeting capability aims to create unique, next-generation bi-specific CAR-T cells
- Significant...